Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.

Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, Yeatts SD, Tamariz D, Ryckborst K; ALIAS Investigators..

Stroke. 2011 Jan;42(1):119-27. doi: 10.1161/STROKEAHA.110.596072. Epub 2010 Dec 16.


The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis.

Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ, Moy CS, Barsan WG, Ginsberg MD; ALIAS Investigators.; Neurological Emergencies Treatment Trials Network..

Stroke. 2011 Jun;42(6):1621-5. doi: 10.1161/STROKEAHA.110.610980. Epub 2011 May 5.


The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.

Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D.

Stroke. 2006 Aug;37(8):2100-6. Epub 2006 Jun 29.


The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.

Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD.

Stroke. 2006 Aug;37(8):2107-14. Epub 2006 Jun 29.


High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.

Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, Waldman BD, Tamariz D, Ryckborst KJ; ALIAS and Neurological Emergencies Treatment Trials (NETT) Investigators..

Lancet Neurol. 2013 Nov;12(11):1049-58. doi: 10.1016/S1474-4422(13)70223-0. Epub 2013 Sep 27.


Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology.; Technology Assessment Committee of the Society of Interventional Radiology..

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.


ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2.

Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY; ALIAS Parts 1 and 2 and NETT Investigators..

Stroke. 2016 Sep;47(9):2355-9. doi: 10.1161/STROKEAHA.116.012825. Epub 2016 Jul 26.


Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Hill MD, Martin RH, Palesch YY, Moy CS, Tamariz D, Ryckborst KJ, Jones EB, Weisman D, Pettigrew C, Ginsberg MD.

PLoS One. 2015 Sep 1;10(9):e0131390. doi: 10.1371/journal.pone.0131390. eCollection 2015.


Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.

Ginsberg MD, Hill MD.

Int J Stroke. 2015 Jun;10(4):494-500. doi: 10.1111/ijs.12476. Epub 2015 Mar 22.


The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report.

Ginsberg MD, Palesch YY, Hill MD.

Biochem Soc Trans. 2006 Dec;34(Pt 6):1323-6.


Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.

Gerischer LM, Fiebach JB, Scheitz JF, Audebert HJ, Endres M, Nolte CH.

Cerebrovasc Dis. 2013;35(3):250-6. doi: 10.1159/000347071. Epub 2013 Mar 26.


The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.

Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; CLEAR Trial Investigators..

Stroke. 2008 Dec;39(12):3268-76. doi: 10.1161/STROKEAHA.108.517656. Epub 2008 Sep 4.


Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).

Mishra NK, Diener HC, Lyden PD, Bluhmki E, Lees KR; VISTA Collaborators..

Stroke. 2010 Dec;41(12):2840-8. doi: 10.1161/STROKEAHA.110.586206. Epub 2010 Oct 28. Erratum in: Stroke. 2011 Jan;42(1):e13.


Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measure.

Mishra NK, Shuaib A, Lyden P, Diener HC, Grotta J, Davis S, Davalos A, Ashwood T, Wasiewski W, Lees KR; Stroke Acute Ischemic NXY Treatment I Trialists..

Stroke. 2011 Apr;42(4):1046-50. doi: 10.1161/STROKEAHA.110.601302. Epub 2011 Feb 24.


CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.

Alexandrov AV, Wojner AW, Grotta JC; CLOTBUST Investigators..

J Neuroimaging. 2004 Apr;14(2):108-12.


Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).

Adams HP Jr, Effron MB, Torner J, Dávalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, Hacke W; AbESTT-II Investigators..

Stroke. 2008 Jan;39(1):87-99. Epub 2007 Nov 21.


Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results.

Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD; ICTuS-L Investigators..

Stroke. 2010 Oct;41(10):2265-70. doi: 10.1161/STROKEAHA.110.592295. Epub 2010 Aug 19.

Supplemental Content

Support Center